MS LifeLines Ambassadors: People Living with MS
MS LifeLines Ambassadors are people who are living with relapsing multiple sclerosis and taking Rebif® (interferon beta-1a) who have chosen to share their experiences and offer hope and encouragement to you.
You can connect one-on-one with an MS LifeLines Ambassador through the Peer Connection program and speak to them openly about your concerns.
"If I can turn something bad into something good and it helps one person, then that's what I want to try to do."—Jordan, MS LifeLines Ambassador, is sponsored by EMD Serono, Inc. and Pfizer Inc.
You can also hear from MS LifeLines Ambassadors at web events and local events and read about them in MS LifeLines magazine.
They can help by:
- Sharing a personal, first-hand account of their experience
- Offering inspiration and tips
- Listening to your concerns and offering encouragement and support
MS LifeLines Ambassadors David and Joni have chosen to candidly share their insights and personal stories of living with relapsing MS through online journals. Read some of their latest posts!
These stories reflect the personal experiences of several people, and others can be different. Results and experiences vary from patient to patient. It is best to contact your doctor to discuss what's best for you. MS LifeLines Ambassadors are living with relapsing MS and sponsored by EMD Serono, Inc. and Pfizer Inc.
Indication
- Rebif is used to treat relapsing forms of MS to decrease the frequency of relapses and delay the occurrence of some of the physical disability that is common in people with MS.
- Rebif is not approved for treatment of chronic progressive MS.
- Rebif is available in 22 mcg and 44 mcg prefilled, preassembled syringes and a titration pack by prescription only.
Important Safety Information
Before beginning treatment, patients should discuss with their doctor the potential benefits and risks associated with Rebif.
Let your doctor know:
- If you have a history of depression, seizures, liver disease, thyroid problems, or blood cell count or bleeding problems, or if you have had previous allergic reactions to medications.
- About all medicines you take, including prescription and non-prescription medicines, vitamins, and herbal supplements. Rebif and other medicines may affect each other, causing serious side effects.
- Before you take any new medicines.
Rebif is not recommended for women who are or plan to become pregnant.
Potential serious side effects of Rebif include:
- Depression and risk of suicide
- Liver problems
- Risk to pregnancy
- Injection-site problems
- Severe allergic reactions. Allergic reactions are rare and may be associated with difficulty in breathing and loss of consciousness, which require immediate medical attention.
The most common side effects with Rebif are:
- Injection-site reactions
- Flu-like symptoms (fever, chills, muscle aches, tiredness)
- Depression
- Abdominal pain
- Increased liver enzymes
- Blood cell count decreases
Let your doctor know if you have any of these symptoms or feel sad, tired, hot or cold, or experience hives, rashes, bruising, yellowing of the skin, or a change in body weight (gain or loss).
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
This information is not intended to replace discussions with your doctor. For additional information about Rebif, please consult the Prescribing Information and Medication Guide and talk to your doctor. You can also call toll-free 1-877-44-REBIF (1-877-447-3243). Rebif is available by prescription only.
MS LifeLines is an educational support service for people living with MS and their families. MS LifeLines and MS LifeLines Ambassadors are sponsored by EMD Serono, Inc. and Pfizer Inc. Speakers and MS LifeLines Ambassadors who participate in Talk MS or in live events are sponsored by EMD Serono, Inc. and Pfizer Inc. UNIQUELY [you] is a service mark of EMD Serono, Inc. or its affiliates. Rebif, Rebiject II and MS LifeLines are registered trademarks and the Rebif logo is a trademark of EMD Serono, Inc. or its affiliates.
Brought to you by EMD Serono, Inc. and Pfizer Inc, the co-marketers of Rebif® (interferon beta-1a) in the US.
This information is intended only for residents of the United States.
Copyright © 2011 EMD Serono, Inc. All rights reserved.
EMD Serono, Inc., One Technology Place, Rockland, MA 02370
